South Korea
Full-Life Technologies and SK Biopharmaceuticals Ink $571.5 Million Deal for Exclusive Rights to Radiopharmaceutical FL-091
Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement wit...
July 17, 2024 | News
ADM Korea to Submit IND for Niclosamide-Based Combination Therapy for Prostate Cancer
IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. Niclosamide-based metab...
July 12, 2024 | News
Genexine Merges with EPD Bio to Advance Targeted Protein Degradation Technology
Merger with EPD Bio, a biotech developing a target protein degrader (TPD) platform technology Jaehyun Choi, Ph.D. founder and CEO of EPD Bio, join...
July 08, 2024 | News
South Korea's Genexine Merges with EPD Biotherapeutics to Enhance PROTAC Technology and Drug Pipeline
Genexine a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the tre...
July 05, 2024 | News
LOTTE BIOLOGICS Breaks Ground on Inaugural Plant at Songdo Bio Campus
LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheo...
July 05, 2024 | News
South Korea's PharmAbcine Advances Novel nAMD Treatment PMC-403 to Key Phase 1 Milestones
PharmAbcine, a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today the decision to advance ...
July 02, 2024 | News
HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries
Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...
July 02, 2024 | News
Alteogen Subsidiary Altos Biologics Submits MAA to EMA for ALT-L9 Aflibercept Biosimilar
Alteogen Inc. announced that its subsidiary, Altos Biologics Inc. has submitted Marketing Authorization Application (MAA) to the European Medicines Ag...
July 02, 2024 | News
CBC Group and Hasten Biopharmaceutical Acquire Asset Rights of 14 Branded Products from Celltrion in Major Pan-Asia Expansion
CBC Group (“CBC”), Asia’s largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its control...
July 01, 2024 | News
South Korea Approves Reimbursement for Antengene's XPOVIO®, Expanding Access to Relapsed/Refractory Multiple Myeloma Treatment
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treat...
June 27, 2024 | News
Hyundai Bioscience Develops Innovative Niclosamide-Based Multi-Treatment Drug for Mosquito-Borne Viral Infections
Developed a 'Niclosamide-based multi-treatment drug' that can simultaneously treat mosquito-borne viral infections such as four serotypes of dengue virus...
June 26, 2024 | News
GC Cell and Bifarma Forge Strategic Partnership to Pioneer Cell Therapy Market in Indonesia
GC Cell, a fully integrated cell and gene therapy pioneer, is proud to announce the establishment of an MOU for strategic partnership with Bifarma, a ...
June 20, 2024 | News
GC Biopharma and Novel Pharma Receive FDA Fast Track Designation for Sanfilippo Syndrome Treatment GC1130A
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfili...
June 11, 2024 | News
DeepQure Initiates Early Feasibility Study for Groundbreaking HyperQure™ System Following FDA Approval
DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), announce...
June 11, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
